Associations between plasma C-reactive protein levels and the severities of coronary and aortic atherosclerosis

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 5, 2010, Pages 460-467

  Momiyama, Yukihiko ^a   Ohmori, Reiko ^b   Fayad, Zahi A ^d   Kihara, Teruyoshi ^c   Tanaka, Nobukiyo ^b   Kato, Ryuichi ^b   Taniguchi, Hiroaki ^b   Nagata, Masayoshi ^c   Nakamura, Haruo ^b   Ohsuzu, Fumitaka ^b  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c Iruma Heart Hospital   (Japan)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aortic plaque; C reactive protein; Coronary artery disease; MRI

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTA; ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; AORTA ATHEROSCLEROSIS; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SMOKING; THORACIC AORTA;

EID: 77953353602     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.2931     Document Type: Article

References (33)

1. Alexander RW: Inflammation and coronary heart disease. N Engl J Med, 1994; 331: 468-469
2. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med, 1999; 340: 115-126
3. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A: The prognostic value of C-re-active protein and serum amyloid A protein in severe unstable angina. N Eng J Med, 1994; 331: 417-424
4. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group: Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet, 1997; 349: 462-466
5. Zebrack JS, Muhlestein JB, Horne BD, Anderson JL, for the Intermountain Heart Collaboration Study Group: C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol, 2002; 39: 632-637
6. Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO, Kropf J, Kerber S, Breithardt G, Assmann G, Cullen P: Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler ThrombVasc Biol, 1999; 19: 2355-2363
7. Rifai N, Joubran R, Yu H, Asmi M, Jouma M: Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem, 1999; 45: 1967-1973
8. Azar RR, Aoun G, Fram DB, Waters DD, Wu AHB, Kiernan FJ: Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests. Am J Cardiol, 2000; 86: 205-208
9. Hoffmeister A, Rothenbacher D, Bazner U, Frohlich M, Brenner H, Hombach V, Koenig W: Role of novel markers of inflammation in patients with stable coronary heart disease. Am J Cardiol, 2001; 87: 262-266
10. Taniguchi H, Momiyama Y, Ohmori R, Yonemura A, Yamashita T, Tamai S, Nakamura H, Ohsuzu F: Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atherosclerosis, 2005; 178: 173-177
11. Roberts JC Jr, Moses C, Wilkins RH: Autopsy studies in atherosclerosis I: distribution and severity of atherosclerosis in patients dying without morphologic evidence of atherosclerotic catastrophe. Circulation, 1959; 20: 511-519
12. Robert JC Jr, Wilkins RH, Moses C: Autopsy studies in atherosclerosis II: distribution and severity of atherosclerosis in patients dying with morphologic evidence of atherosclerotic catastrophe. Circulation, 1959; 20: 520-526
13. Fayad ZA, Nahar T, Fallon JT, Goldman M, Aguinaldo JG, Badimon JJ, Shinnar M, Chesebro JH, Fuster V: In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation, 2000; 101: 2503-2509
14. Taniguchi H, Momiyama Y, Fayad ZA, Ohmori R, Ashida K, Kihara T, Hara A, Arakawa K, Kameyama A, Noya K, Nagata M, Nakamura H, Ohsuzu F: In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography. Am Heart J, 2004; 148: 137-143
15. Ashida K, Momiyama Y, Fayad ZA, Tanaka N, Kato R, Taniguchi H, Ohmori R, Kihara T, Kameyama A, Nagata M, Nakamura H, Ohsuzu F: Magnetic resonance evaluation of the associations of thoracic and abdominal aortic plaques with the presence and extent of coronary artery stenosis. J Cardiovasc Magn Reson, 2007; 9: 855-861
16. Jaffer FA, O'Donnell CJ, Larson MG, Chan SK, Kissinger KV, Kupka MJ, Salton C, Botnar RM, Levy D, Manning WJ: Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler Thromb Vasc Biol, 2002; 22: 849-854
17. Worthley SG, Helft G, Fuster V, Fayad ZA, Fallon JT, Osende JI, Roque M, Shinnar M, Zaman AG, Rodriguez OJ, Verhallen P, Badimon JJ: High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. Atherosclerosis, 2000; 150: 321-329
18. Helft G, Worthley SG, Fuster V, Zaman AG, Schechter C, Osende JI, Rodriguez OJ, Fayad ZA, Fallon JT, Badimon JJ: Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. J Am Coll Cardiol, 2001; 37: 1149-1154
19. Skinner MP, Yuan C, Mitsumori L, Hayes CE, Raines EW, Nelson JA, Ross R: Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nature Med, 1995; 1: 69-73
20. Takasu J, Katz R, Shavelle DM, O'Brien K, Mao SS, Carr JJ, Cushman M, Budoff MJ: Inflammation and descending thoracic aortic calcification as detected by computed tomography: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis, 2008; 199: 201-206
21. Agmon Y, Khandheria BK, Meissner I, Petterson TM, O'Fallon WM, Wiebers DO, Christianson TJH, McConnell JP, Whisnant JP, Seward JB, Tajik AJ: C-reactive protein and atherosclerosis of the thoracic aorta: a population-based transesophageal\echocardiographic study. Arch In-tern Med, 2004; 164: 1781-1787
22. Elias-Smale SE, Kardys I, Oudkerk M, Hofman A, Witte-man JCM: C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis: results from the Rotterdam study. Atherosclerosis, 2007; 195: e195-202
23. Hommels MJ, van der Ven AJAM, Kroon AA, Kessels AGH, van Dieijen-Visser MP, van Engelshoven JAM, Bruggeman CA, de Leeuw PW: C-reactive protein, atherosclerosis and kidney function in hypertensive patients. J Hum Hypertens, 2005; 19: 521-526
24. Zieske AW, Tracy RP, McMahan CA, Herderick EE, Homma S, Malcom GT, McGill Jr HC, Strong JP: Elevated serum C-reactive protein levels and advanced atherosclerosis in youth. Arterioscler Thromb Vasc Biol, 2005; 25: 1237-1243
25. Tribouilloy CM, Peltier M, Lannetta-Peltier MC, Zhu Z, Andrejak M, Lesbre JP: Relation between low-density lipoprotein cholesterol and thoracic aortic atherosclerosis. Am J Cardiol, 1999; 84: 603-605
26. Giral P, Pithois-Merli I, Filitti V, et al: Prevention Cardiovasculaire en Medecine du Travail METRA Group. Risk factors and early extracoronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholester-olemic men. Arch Intern Med, 1991; 151: 950-956
27. McGill Jr HC: The cardiovascular pathology of smoking. Am Heart J, 1988; 115: 250-257
28. Reed D, Reed C, Stemmermann G, Hayashi T: Are aortic aneurysms caused by atherosclerosis? Circulation, 1992; 85: 205-211
29. Dobrin P, Baker W, Gley W: Elastolytic and collagenolytic studies of arteries. Arch Surg, 1984; 119: 405-409
30. Agmon Y, Khandheria BK, Meissner I, Schwartz GL, Petterson TM, O'Fallon WM, Whisnant JP, Wiebers DO, Seward JB: Relation of coronary artery disease and cere-brovascular disease with atherosclerosis of the thoracic aorta in the general population. Am J Cardiol, 2002; 89: 262-267
31. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E, for the Cholesterol and Recurrent Events (CARE) Investigators: Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation, 1999; 100: 230-235
32. Plenge JK, Hernandez TL, Weil KM, Poirier P, Grunwald GK, Marcovina SM, Eckel RH: Simvastatin lowers C-re-active protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation, 2002; 106: 1447-1452
33. Koshiyama H, Taniguchi A, Tanaka K, Kagimoto S, Fujioka Y, Hirata K, Nakamura Y, Iwakura A, Hara K, Yamamoto T, Kuroe A, Ohya M, Fujimoto S, Hamamoto Y, Honjo S, Ikeda H, Nabe K, Tsuda K, Inagaki N, Seino Y, Kume N: Effects of pitavastatin on lipid profiles and high-sensitivity CRP in Japanese subjects with hypercholesterolemia: Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology (KISHIMEN) Investigators. J Atheroscler Thromb, 2008; 15: 345-350